Edoxaban Ester Impurity
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1093351-29-1Edoxaban Ester Impurity

● In Stock

Catalogue No.:VE0023140
CAS No.:1093351-29-1
Mol. Formula:C24H29ClN6O5S
Mol. Weight:549.04 g/mol

Additional information on CAS 1093351-29-1

Parent drug

Edoxaban

IUPAC Name

(1S, 3R, 4S)-ethyl 4-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-3-(5-methyl-4, 5, 6, 7-tetrahydrothiazolo[5, 4-c]pyridine-2-carboxamido)cyclohexanecarboxylate

Other Synonyms

Edoxaban Ethyl Ester

Smiles

O=C([C@@H]1C[C@@H](NC(C(S2)=NC3=C2CN(C)CC3)=O)[C@@H](NC(C(NC4=NC=C(Cl)C=C4)=O)=O)CC1)OCC

InChI

InChI=1S/C24H29ClN6O5S/c1-3-36-24(35)13-4-6-15(27-20(32)21(33)30-19-7-5-14(25)11-26-19)17(10-13)28-22(34)23-29-16-8-9-31(2)12-18(16)37-23/h5, 7, 11, 13, 15, 17H, 3-4, 6, 8-10, 12H2, 1-2H3, (H, 27, 32)(H, 28, 34)(H, 26, 30, 33)/t13-, 15-, 17+/m0/s1

Description

Edoxaban Ester Impurity is a meticulously characterized reference material that complies with rigorous regulatory requirements | including those defined by USP | EMA | JP | and BP. This product plays a crucial role in Abbreviated New Drug Applications (ANDA) | New Drug Applications (NDA) | and the commercial manufacturing of Edoxaban. It is further supported by a detailed Structure Elucidation Report (SER) | ensuring high accuracy and reliability across a broad range of analytical applications.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url